CCWM
ABBV icon

Cassaday & Co Wealth Management’s AbbVie ABBV Stock Holding History

Cassaday & Co Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.24M Buy
20,820
+145
+0.7% +$31.2K 0.1% 49
2026
Q1 		$4.5M Sell
20,675
-60
-0.3% -$13.3K 0.1% 46
2025
Q4 		$4.74M Sell
20,735
-211
-1% -$48.1K 0.1% 46
2025
Q3 		$4.85M Buy
20,946
+212
+1% +$43.2K 0.11% 47
2025
Q2 		$3.85M Buy
20,734
+144
+0.7% +$26.8K 0.1% 52
2025
Q1 		$4.31M Sell
20,590
-252
-1% -$49K 0.12% 42
2024
Q4 		$3.7M Buy
20,842
+75
+0.4% +$13.8K 0.1% 46
2024
Q3 		$4.1M Sell
20,767
-208
-1% -$38.8K 0.12% 40
2024
Q2 		$3.6M Sell
20,975
-98
-0.5% -$16.2K 0.11% 43
2024
Q1 		$3.84M Buy
21,073
+469
+2% +$80.8K 0.12% 42
2023
Q4 		$3.19M Sell
20,604
-272
-1% -$39.7K 0.11% 43
2023
Q3 		$3.11M Sell
20,876
-179
-0.9% -$26.3K 0.13% 39
2023
Q2 		$2.84M Sell
21,055
-85
-0.4% -$12.5K 0.11% 41
2023
Q1 		$3.37M Sell
21,140
-341
-2% -$52.1K 0.14% 36
2022
Q4 		$3.47M Buy
+21,481
New +$3.29M 0.16% 36

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cassaday & Co Wealth Management's ABBV Position: Q2 2026 in Review

Cassaday & Co Wealth Management increased its AbbVie (ABBV) stake by 0.7% in Q2 2026, buying an estimated $31.2K and bringing the position to 20,820 shares worth $5.24M. The position accounts for 0.1% of the portfolio, ranked #49.

Cassaday & Co Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cassaday & Co Wealth Management held 20,820 shares of AbbVie worth $5.24M as of Q2 2026.
  • Cassaday & Co Wealth Management bought 145 AbbVie shares in Q2 2026, an estimated $31.2K.
  • AbbVie made up 0.1% of Cassaday & Co Wealth Management's portfolio in Q2 2026, its #49 holding.
  • Cassaday & Co Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.